All stories tagged :

Pr Newswire

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy...

admin
Pr Newswire

argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating...

admin
Pr Newswire

Sciwind Biosciences to Highlight Positive Results for Injectable Ecnoglutide (Phase 3),...

admin
Pr Newswire

New MiniMed™ 780G system data demonstrates ability to address persistent blood...

admin
Pr Newswire

FP Markets Adds Two More Industry Benchmark Awards to Its Collection

admin
Pr Newswire

2024 World Intelligence Expo Begins with a Grand Opening in Tianjin

admin
Pr Newswire

Discover VIAIM’s Advanced Earbuds: Elevate Your Smart Office Experience with Real-time...

admin
Pr Newswire

Lexicon Pharmaceuticals Resubmits Sotagliflozin NDA for Type 1 Diabetes

admin
Pr Newswire

Aprea Therapeutics to Host Virtual KOL Event on APR-1051, a Highly...

admin
Pr Newswire

Acasti Announces Year-End 2024 Financial Results, Provides Business Update

admin
Pr Newswire

Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on...

admin

Featured

Pr Newswire

Virbac : Declaration of the number of shares and voting rights...

admin
Pr Newswire

Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa’s...

admin
Pr Newswire

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase...

admin
Pr Newswire

Strüngmann Award Honors Araris Biotech Founding Team as 2025 Winner

admin
admin

Virbac : Declaration of the number of shares and voting rights...

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal...